Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LRN

Today 19:17 EST

From The Rosen Law Firm PA

Via GlobeNewswire

Balancer Announcement: If You Have Suffered Losses in Balancer Cryptocurrency, You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Today 17:59 EST

From The Rosen Law Firm PA

Via GlobeNewswire

CRMT Investor News: If You Have Suffered Losses in America’s Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Today 17:34 EST

From The Rosen Law Firm PA

Via GlobeNewswire

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Today 17:30 EST

From Fulcrum Therapeutics, Inc.

Via GlobeNewswire

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

Today 17:30 EST

From TScan Therapeutics, Inc.

Via GlobeNewswire

DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

Today 16:39 EST

From The Rosen Law Firm PA

Via GlobeNewswire

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

Today 15:30 EST

From BioNTech SE

Via GlobeNewswire

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Today 14:55 EST

From The Rosen Law Firm PA

Via GlobeNewswire

Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness

Today 14:01 EST

From Remedy's Nutrition

Via GlobeNewswire

Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025

Today 14:00 EST

From Legend Biotech USA Inc.

Via GlobeNewswire

THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality

Today 13:51 EST

From USA News Group

Via GlobeNewswire

AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Today 13:36 EST

From The Rosen Law Firm PA

Via GlobeNewswire

Anthony Constantino’s ‘Thank You President Trump’ Album Release To Light Up Fontainebleau LIV Tonight; Hit song “Fight” has over 4 million views in 5 days

Today 11:24 EST

From Sticker Mule

Via GlobeNewswire

Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs

Today 11:00 EST

From Prelude Therapeutics, Incorporated

Via GlobeNewswire

BLUE OWL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Blue Owl Capital, Inc. and Encourages Investors to Contact the Firm

Today 9:25 EST

From Bragar Eagel & Squire

Via GlobeNewswire

CEPTON URGENT ALERT: Bragar Eagel & Squire, P.C. Reminds Cepton Stockholders of Upcoming December 8th Lead Plaintiff Deadline

Today 9:14 EST

From Bragar Eagel & Squire

Via GlobeNewswire

MAREX URGENT DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Marex Stockholders to Contact the Firm Before December 8th Deadline

Today 9:05 EST

From Bragar Eagel & Squire

Via GlobeNewswire

ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights

Today 8:53 EST

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STUB

Today 8:34 EST

From The Rosen Law Firm PA

Via GlobeNewswire

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Today 8:30 EST

From Adaptive Biotechnologies

Via GlobeNewswire

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human

Today 8:05 EST

From Io Therapeutics, Inc.

Via GlobeNewswire

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

Today 8:05 EST

From Arvinas Inc.

Via GlobeNewswire

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

Today 8:00 EST

From Beam Therapeutics

Via GlobeNewswire

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

Today 8:00 EST

From Aptose Biosciences, Inc.

Via GlobeNewswire

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Today 8:00 EST

From Disc Medicine Inc

Via GlobeNewswire

Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026

Today 8:00 EST

From Bicara Therapeutics Inc.

Via GlobeNewswire

Cardinal Point Wealth Management Releases New 2025 Cross-Border Retirement Guide for High-Net-Worth Families

Today 0:55 EST

From Cardinal Point Wealth Management, ULC

Via GlobeNewswire

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

December 05, 2025

From Junshi Biosciences

Via GlobeNewswire

Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease

December 05, 2025

From Cerevance, Inc.

Via GlobeNewswire

Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK

December 05, 2025

From Kirby McInerney LLP

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.